miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells

Huaping Tang(Sichuan Agricultural University), Yueqin Hao(Qingdao Municipal Hospital)
International Journal of Molecular Medicine
December 31, 2018
Cited by 21


Related Papers